ADAGIO THERAPEUTICS INC's ticker is and the CUSIP is 00534A102. A total of 68 filers reported holding ADAGIO THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $826,000 | – | 20,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 6,398,250 | $29,176,000 | 26.83% |
| Foresite Capital Management V, LLC | 1,431,826 | $6,529,000 | 2.67% |
| Slate Path Capital LP | 3,735,000 | $17,032,000 | 0.87% |
| Bain Capital Life Sciences Investors, LLC | 1,937,207 | $8,834,000 | 0.86% |
| Alphabet Inc. | 5,680,785 | $25,904,000 | 0.84% |
| 683 Capital Management, LLC | 2,350,000 | $10,716,000 | 0.57% |
| Orbimed Advisors | 5,056,000 | $23,055,000 | 0.37% |
| Redmile Group, LLC | 1,920,960 | $8,760,000 | 0.27% |
| Artal Group S.A. | 1,000,000 | $4,560,000 | 0.19% |
| Triatomic Management LP | 25,800 | $118,000 | 0.10% |